Browse result page of B3Pdb

The total number entries retrieved from this search are 24, scroll left/right for detailed information.

B3pdbID	PEPTIDE NAME	PEPTIDE SEQUENCE (1-letter)	PEPTIDE SEQUENCE (3-letter)	N-TERMINAL MODIFICATION	C-TERMINAL MODIFICATION	CHEMICAL MODIFICATION	PEPTIDE LENGTH	PEPTIDE CONFORMATION	PEPTIDE NATURE	SOURCE/ORIGIN OF PEPTIDE	SMILES	CELL LINE	In vitro CONCENTRATION	In vitro METHOD	In vitro RESULT	ANIMAL MODEL	In vivo CONCENTRATION	In vivo MODE OF DELIVERY	In vivo METHOD	In vivo RESULT	ACTION	TRANSPORT TYPE	SUBCELLULAR LOCALISATION	COMBINATION	PHYSICAL CONDITION	RESPONSE	RESULT	LABEL	PMID
B3pdbIDb3pdb_0408	PEPTIDE NAMEOxytocin	PEPTIDE SEQUENCE (1-letter)CYIQNCPLG	PEPTIDE SEQUENCE (3-letter)Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly	N-TERMINAL MODIFICATION	C-TERMINAL MODIFICATION	CHEMICAL MODIFICATIONCys1-Cys6	PEPTIDE LENGTH9	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEhuman,bovine,mouse,rat	SMILESO=C(O)CNC(=O)[C@H](NC(=O)[C@H]3N(C(=O)[C@H]1NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](N)CSSC1)Cc2ccc(O)cc2)[C@@H](C)CC)CCC(=O)N)CC(=O)N)CCC3)CC(C)C	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntracarotid injection	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEVolume of donor compartment	RESULT0.00815 ml/g	LABELH3/C14	PMID 10976589
B3pdbIDb3pdb_0409	PEPTIDE NAMEThyrotropin releasin	PEPTIDE SEQUENCE (1-letter)Pyr-HP	PEPTIDE SEQUENCE (3-letter)Pyr-His-Pro	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH3	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEhuman,mouse,rat	SMILESO=C(N1[C@H](C(=O)O)CCC1)[C@H](NC(=O)[C@H]2NC(=O)CC2)Cc3ncnc3	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntracarotid injection	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEBlood/brain ratio	RESULT132	LABELDirect iodination	PMID 2413968
B3pdbIDb3pdb_0499	PEPTIDE NAMEExendin-3	PEPTIDE SEQUENCE (1-letter)HSDGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS	PEPTIDE SEQUENCE (3-letter)His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH31	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDErat	SMILES[H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntracarotid injection	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEBlood/brain ratio	RESULT101	LABELDirect iodination	PMID 2413968
B3pdbIDb3pdb_0519	PEPTIDE NAME[Met5] Enkephalin	PEPTIDE SEQUENCE (1-letter)YGGFM	PEPTIDE SEQUENCE (3-letter)Tyr-Gly-Gly-Phe-Met	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH5	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEmouse,rat	SMILESO=C(O)C(NC(=O)C(NC(=O)CNC(=O)CNC(=O)C(N)Cc1ccc(O)cc1)Cc2ccccc2)CCSC	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntracarotid injection	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEBlood/brain ratio	RESULT48	LABELDirect iodination	PMID 2413968
B3pdbIDb3pdb_0522	PEPTIDE NAME[Leu5] Enkephalin	PEPTIDE SEQUENCE (1-letter)YGGFL	PEPTIDE SEQUENCE (3-letter)Tyr-Gly-Gly-Phe-Leu	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH5	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDENA	SMILESO=C(O)C(NC(=O)C(NC(=O)CNC(=O)CNC(=O)C(N)Cc1ccc(O)cc1)Cc2ccccc2)CC(C)C	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntracarotid injection	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEBlood/brain ratio	RESULT69	LABELDirect iodination	PMID 2413968
B3pdbIDb3pdb_0648	PEPTIDE NAMEUrocortin III	PEPTIDE SEQUENCE (1-letter)FTLSLDVPTNIMNLLFNIAKAKNLRAQAAANAHLMAQI	PEPTIDE SEQUENCE (3-letter)Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile-Met-Asn-Leu-Leu-Phe-Asn-Ile-Ala-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Gln-Ala-Ala-Ala-Asn-Ala-His-Leu-Met-Ala-Gln-Ile	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH38	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEmouse	SMILESN[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])([C@]([H])(O)C)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(C(C)C)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])([C@]([H])(O)C)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(CCSC)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CCSC)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntracarotid injection	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEBlood/brain ratio	RESULT92	LABELDirect iodination	PMID 2413968
B3pdbIDb3pdb_0655	PEPTIDE NAMELuteinizing hormone-	PEPTIDE SEQUENCE (1-letter)Pyr-HWSYGLRPG	PEPTIDE SEQUENCE (3-letter)Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH10	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEmouse	SMILESO=C(NCC(=O)O)[C@H]6N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H]1NC(=O)CC1)Cc2ncnc2)Cc4c3ccccc3nc4)CO)Cc5ccc(O)cc5)CC(C)C)CCCNC(=[N@H])N)CCC6	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntracarotid injection	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEBlood/brain ratio	RESULT126	LABELDirect iodination	PMID 2413968
B3pdbIDb3pdb_0675	PEPTIDE NAMEα Melanocyte stimula	PEPTIDE SEQUENCE (1-letter)Ac-SYSMEHFRWGKPV	PEPTIDE SEQUENCE (3-letter)Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH13	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEmouse,rat	SMILESO=C(N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)O)C(C)C)CCC1)CCCCN)Cc3c2ccccc2nc3)CCCNC(=[N@H])N)Cc4ccccc4)Cc5ncnc5)CCC(=O)O)CCSC)CO)[C@@H](NC(=O)[C@H](NC(=O)C)CO)Cc6ccc(O)cc6	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntracarotid injection	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEBlood/brain ratio	RESULT108	LABELDirect iodination	PMID 2413968
B3pdbIDb3pdb_0681	PEPTIDE NAMEGlutathione	PEPTIDE SEQUENCE (1-letter)ECG	PEPTIDE SEQUENCE (3-letter)Glu-Cys-Gly	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH3	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDE	SMILESO=C(NCC(=O)O)C(NC(=O)C(N)CCC(=O)O)CS	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntracarotid injection	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEBUI	RESULT22.60%	LABEL35-S	PMID 1971830
B3pdbIDb3pdb_0743	PEPTIDE NAMESubstance P	PEPTIDE SEQUENCE (1-letter)RPKPQQFFGLM-NH2	PEPTIDE SEQUENCE (3-letter)Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH11	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEChemically synthesized	SMILESO=C(N)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C2N(C(=O)C(NC(=O)C1N(C(=O)C(N)CCCNC(=[N@H])N)CCC1)CCCCN)CCC2)CCC(=O)N)CCC(=O)N)Cc3ccccc3)Cc4ccccc4)CC(C)C)CCSC	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntracarotid injection	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEBlood/brain ratio	RESULT258	LABELDirect iodination	PMID 2413968
B3pdbIDb3pdb_1012	PEPTIDE NAMEN-Tyr-Delta Sleep In	PEPTIDE SEQUENCE (1-letter)YWAGGDASGE	PEPTIDE SEQUENCE (3-letter)Tyr-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH10	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEsynthetic,viral	SMILESC[C@@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC3=CC=C(C=C3)O)N	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntracarotid injection	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSE% injected dose	RESULT0.18 %/g	LABELDirect iodination	PMID 6897680
B3pdbIDb3pdb_1013	PEPTIDE NAMEN-Tyr-Delta Sleep In	PEPTIDE SEQUENCE (1-letter)YWAGGDASGE	PEPTIDE SEQUENCE (3-letter)Tyr-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH10	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEsynthetic,viral	SMILESC[C@@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC3=CC=C(C=C3)O)N	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntracarotid injection	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSE% injected dose	RESULT0.22 %/g	LABELDirect iodination	PMID 6897680
B3pdbIDb3pdb_1014	PEPTIDE NAMEN-Tyr-Delta Sleep In	PEPTIDE SEQUENCE (1-letter)YWAGGDASGE	PEPTIDE SEQUENCE (3-letter)Tyr-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH10	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEsynthetic,viral	SMILESC[C@@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC3=CC=C(C=C3)O)N	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntracarotid injection	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEBrain to plasma ratio	RESULT0.00556	LABELDirect iodination	PMID 6897680
B3pdbIDb3pdb_1015	PEPTIDE NAMEN-Tyr-Delta Sleep In	PEPTIDE SEQUENCE (1-letter)YWAGGDASGE	PEPTIDE SEQUENCE (3-letter)Tyr-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH10	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEsynthetic,viral	SMILESC[C@@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC3=CC=C(C=C3)O)N	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntracarotid injection	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEBrain to plasma ratio	RESULT0.00275	LABELDirect iodination	PMID 6897680
B3pdbIDb3pdb_1016	PEPTIDE NAMEN-Tyr-Delta Sleep In	PEPTIDE SEQUENCE (1-letter)YWAGGDASGE	PEPTIDE SEQUENCE (3-letter)Tyr-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH10	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEsynthetic,viral	SMILESC[C@@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC3=CC=C(C=C3)O)N	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntracarotid injection	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEBlood/brain ratio	RESULT116	LABELDirect iodination	PMID 6897680
B3pdbIDb3pdb_1017	PEPTIDE NAMEGastrin-releasing pe	PEPTIDE SEQUENCE (1-letter)NA	PEPTIDE SEQUENCE (3-letter)NA	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTHNA	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEChemically synthesized	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntracarotid injection	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEBlood/brain ratio	RESULT62	LABELDirect iodination	PMID 2413968
B3pdbIDb3pdb_1020	PEPTIDE NAMEArginine vasopressin	PEPTIDE SEQUENCE (1-letter)CYFQNCPRG	PEPTIDE SEQUENCE (3-letter)Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONCys1-Cys6	PEPTIDE LENGTH9	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEChemically synthesized	SMILESC1C[C@H](N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntracarotid injection	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEBlood/brain ratio	RESULT142	LABELDirect iodination	PMID 2413968
B3pdbIDb3pdb_1021	PEPTIDE NAMEArginine vasopressin	PEPTIDE SEQUENCE (1-letter)CYFQNCPRG	PEPTIDE SEQUENCE (3-letter)Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONCys1-Cys6	PEPTIDE LENGTH9	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEChemically synthesized	SMILESC1C[C@H](N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntracarotid injection	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEBlood/brain ratio	RESULT148	LABELDirect iodination	PMID 2413968
B3pdbIDb3pdb_1024	PEPTIDE NAMEN-Tyr-Corticotropin	PEPTIDE SEQUENCE (1-letter)NA	PEPTIDE SEQUENCE (3-letter)NA	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTHNA	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDENA	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntracarotid injection	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEBlood/brain ratio	RESULT69	LABELDirect iodination	PMID 2413968
B3pdbIDb3pdb_1025	PEPTIDE NAMEN-Tyr-Bovine Adrenal	PEPTIDE SEQUENCE (1-letter)NA	PEPTIDE SEQUENCE (3-letter)NA	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTHNA	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDENA	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntracarotid injection	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEBlood/brain ratio	RESULT80	LABELDirect iodination	PMID 2413968
B3pdbIDb3pdb_1026	PEPTIDE NAMEN-Tyr-β-Endorphin	PEPTIDE SEQUENCE (1-letter)NA	PEPTIDE SEQUENCE (3-letter)NA	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTHNA	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDENA	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntracarotid injection	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEBlood/brain ratio	RESULT93	LABELDirect iodination	PMID 2413968
B3pdbIDb3pdb_1027	PEPTIDE NAMEN-Tyr-Somatostatin	PEPTIDE SEQUENCE (1-letter)NA	PEPTIDE SEQUENCE (3-letter)NA	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTHNA	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDENA	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntracarotid injection	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEBlood/brain ratio	RESULT106	LABELDirect iodination	PMID 2413968
B3pdbIDb3pdb_1028	PEPTIDE NAMEN-Tyr-Growth Hormone	PEPTIDE SEQUENCE (1-letter)NA	PEPTIDE SEQUENCE (3-letter)NA	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTHNA	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDENA	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntracarotid injection	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEBlood/brain ratio	RESULT133	LABELDirect iodination	PMID 2413968
B3pdbIDb3pdb_1029	PEPTIDE NAMEN-Tyr-Molluscan Card	PEPTIDE SEQUENCE (1-letter)NA	PEPTIDE SEQUENCE (3-letter)NA	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTHNA	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDENA	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntracarotid injection	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEBlood/brain ratio	RESULT89	LABELDirect iodination	PMID 2413968